Metsera and Maze Therapeutics priced their Nasdaq IPOs, raising $275M and $140M respectively. Both companies backed by ARCH ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

The pizza chain itself is among the buyers who won the right to buy restaurants owned by the bankrupt EYM Group for nearly ...

Rumors of ICE raids in the first week of Trump's presidency rattled a community that's been preparing for the his promise of ...

A small-scale homeless outreach program that Mayor Adams’ administration launched in late 2022 has proven effective. But the ...

Plus: Help for LA fires victims, Noise Pop's third stellar drop, Joan Baez strums asleep, an '80s coldwave nugget, more music ...

Maze Therapeutics, Inc MAZE IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE. The company is offering shares at an expected price between $15.00 and $17.00 per share with ...

Shopping for solar panels can feel like navigating a maze of sales pitches and confusing quotes. But there's a free tool that ...

Andrew Smith, cofounder of the private-equity firm Savory Fund, joins the podcast to talk about investing in emerging ...

Nearly 23% of Iowa students — more than 33,000 in — reported suicidal thoughts in the past 12 months, according to a 2021 ...

Until this year, the Guinness World Record was held by a nearly 13,000-square-foot ice labyrinth in New York that took the ...